David Esposito

David has built and scaled multiple healthcare companies that resulted in successful exits to strategic buyers. As the CEO, he led Armune BioScience in its 2017 acquisition by Exact Sciences. He was the US President at Phadia US/AB, which was sold to Thermo Fisher Scientific in 2011. He is dedicated to developing programs and resources that help people be their best for those they care about most at home, work, and in the community.